Evidence map›Paper›PMID 37576617›Full record

ReviewACS omega2023

[RhCp*Cl

Amar Nath Singh Chauhan, Ghanshyam Mali, Garima Dua, Priya Samant, Akhilesh Kumar, Rohan D Erande

Open access · goldAbstract readReview
In one paragraph

Review in ACS omega, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 27 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Amar Nath Singh ChauhanDepartment of Chemistry, Indian Institute of Technology Jodhpur, Jodhpur 342037, India.
Ghanshyam MaliDepartment of Chemistry, Indian Institute of Technology Jodhpur, Jodhpur 342037, India.ORCID https://orcid.org/0000-0002-0388-3203
Garima DuaDepartment of Chemistry, Indian Institute of Technology Jodhpur, Jodhpur 342037, India.
Priya SamantDepartment of Chemistry, Indian Institute of Technology Jodhpur, Jodhpur 342037, India.
Akhilesh KumarDepartment of Chemistry and Nano Science, Ewha Womans University, Seoul 03760, Korea.
Rohan D ErandeDepartment of Chemistry, Indian Institute of Technology Jodhpur, Jodhpur 342037, India.ORCID https://orcid.org/0000-0002-8763-5353
Indian Institute of Technology Jodhpur · INEwha Womans University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Polycyclic fused indoles are ubiquitous in natural products and pharmaceuticals due to their immense structural diversity and biological inference, making them suitable for charting broader chemical space. Indole-based polycycles continue to be fascinating as well as challenging targets for synthetic fabrication because of their characteristic structural frameworks possessing biologically intriguing compounds of both natural and synthetic origin. As a result, an assortment of new chemical processes and catalytic routes has been established to provide unified access to these skeletons in a very efficient and selective manner. Transition-metal-catalyzed processes, in particular from rhodium(III), are widely used in synthetic endeavors to increase molecular complexity efficiently. In recent years, this has resulted in significant progress in reaching molecular scaffolds with enormous biological activity based on core indole skeletons. Additionally, Rh(III)-catalyzed direct C-H functionalization and benzannulation protocols of indole moieties were one of the most alluring synthetic techniques to generate indole-fused polycyclic molecules efficiently. This review sheds light on recent developments toward synthesizing fused indoles by cascade annulation methods using Rh(III)-[RhCp*Cl

Identifiers

PMID37576617
PMCPMC10413382
OpenAlexW4385260681

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.